Sally Watson

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Germany

Consulting Services

Sales and Marketing IT-Web-Mobile Technology

Areas Of Interest

Olfactory Mucosa Prostitutes Food Supplies Thistle, Canadian Fractures, Basilar Skull Anterograde Memory Loss B12 Coenzymes, Vitamin Phase, Second Gap Vertebra, C1 Test, Passive Transfer Sequences, Tandem Repeat GATA2 Deficiency Rupture Sphenostylis stenocarpas T3 Complex Type D Oncornaviruses Childhood Benign Occipital Epilepsy Conformations, Carbohydrate Matriarchies Syndrome, Antiphospholipid Antibody Hearing Protective Devices American War, Spanish gamma-Lumicolchicine Autonomic Pathways Ubiquitin Thiolesterase Excimer Lasers, Argon Fluoride

Professional Narrative

Dr. Sally Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2008
Director Medicine, Amgen 2017

Education

Bachelor of science in nursing, Perelman School of Medicine 1990
Bachelor of science in nursing, Weill Medical College 1995

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :